Author/Authors :
Nasri, Peiman Metabolic Liver Disease Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Hosseini-Kordkhyli, Esmaeil Ghaemshahr Razi Hospital - Mazandaran University of Medical Sciences, Sari, Iran , Jafari-Koulaee, Azar Department of Nursing - Faculty of Medical Sciences - Tarbiat Modaress University, Tehran, Iran , Hovsepian, Silva Metabolic Liver Disease Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Saneian, Hossein Metabolic Liver Disease Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Khademian, Majid Metabolic Liver Disease Research Center - Isfahan University of Medical Sciences, Isfahan, Iran , Famouri, Fatemeh Metabolic Liver Disease Research Center - Isfahan University of Medical Sciences, Isfahan, Iran
Abstract :
Background: The specialists should identify the features of Wilson disease and autoimmune
hepatitis when both affect a patient to adopt appropriate treatment.
Objectives: This study was conducted to determine features of the patient, disease, diagnostic studies,
and therapeutic measures in cases of simultaneity of Wilson disease and autoimmune hepatitis.
Methods: To find evidence related to the study objectives, we searched databases such as Barakat
knowledge network system, SID, Magiran, Google Scholar, Web of Science, ProQuest, Springer,
ScienceDirect, Medline via PubMed, and Scopus with specified Persian and English keywords, including
“Wilson’s Disease”, “Autoimmune”, and “Hepatitis”. The inclusion criteria for the studies were 1) the
study was observational and 2) the study was published in Persian or English. The exclusion criteria
included low-quality studies based on the score obtained from the checklist. The obtained studies were
screened in terms of titles, abstracts, and full text, and finally, the qualified studies entered the review
process. The relevant data were extracted according to a designed checklist.
Results: Finally, 10 studies were included in the review process. Information about 14 patients was
reported. The Mean±SD age of the participants in the studies was 19±11 years. The direction of
diagnosis was from autoimmune hepatitis to Wilson disease in 8 cases and from Wilson disease to
autoimmune hepatitis in 3 cases. The simultaneity of autoimmune hepatitis and Wilson disease was
considered in 3 patients with no primary and secondary diagnosis.
Conclusions: The comorbidity of Wilson disease and autoimmune hepatitis is uncommon but is
important. In the presence of relevant symptoms in these patients, the comorbidity of these two
diseases should be considered. Accordingly, additional assessments such as serum ceruloplasmin,
urinary 24-h copper, molecular genetic testing, MRI, serological tests, anti-nuclear antibody, antimitochondrial
antibody, anti-smooth muscle antibody, complement level, gamma globulin, IgG,
albumin, Kayser-Fleischer ring eye examination, and liver biopsy should be considered for correct
diagnosis. If appropriate treatment was started for the disease with a diagnosis of Wilson disease
or autoimmune hepatitis, but the response to treatment was insufficient, it is better to consider the
simultaneous occurrence of two diseases or the initial misdiagnosis.
Keywords :
Autoimmune hepatitis , Wilson disease , Comorbidity , Review